查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1386212

全球颅咽瘤治疗市场：趋势、预测与竞争分析（~2030 年）

Craniopharyngioma Treatment Market Report: Trends, Forecast and Competitive Analysis to 2030
出版日期: | 出版商: Lucintel | 英文 150 Pages | 商品交期: 3个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

颅咽瘤治疗的趋势与预测

预计2030年，全球颅咽瘤治疗市场规模将达到约2,000万美元，2024年至2030年年复合成长率为7.1%。该市场的主要驱动力是全球脑肿瘤盛行率的不断上升、医疗保健支出的增加以及影像技术、放射线治疗和手术技术的不断进步。全球颅咽瘤治疗市场的未来前景广阔，医院、诊所、门诊手术中心、癌症研究机构和诊断实验室市场都有机会。

颅咽瘤治疗市场洞察

Lucintel 预测，由于磁振造影(MRI) 能够创建大脑和脑下垂体的详细图像，因此在预测期内将继续成为最大的细分市场。

在这个市场中，由于医院提供的设施、高技能的医疗保健专业人员以及尖端医疗技术的存在，医院可能仍然是最大的细分市场。

由于该地区颅咽瘤盛行率不断上升、先进的医疗基础设施以及有利的报销政策，北美在预测期内可能仍是最大的市场。

市场规模/估计：以金额的颅咽瘤治疗市场规模估计（10亿美元）

趋势和预测分析：各细分市场和地区的市场趋势（2018-2023）和预测（2024-2030）

細項分析：按诊断、治疗、最终用途行业和地区分類的颅咽瘤治疗市场规模估计金额（十亿美元）

区域分析：北美、欧洲、亚太地区和世界其他地区颅咽瘤治疗市场细分

成长机会：颅咽瘤治疗市场中诊断、治疗、最终用途产业和地区的成长机会分析

策略分析：颅咽瘤治疗市场併购、新产品开发、竞争形势等

基于波特五力模型的产业竞争实力分析

本报告回答了 11 个关键问题：

  • Q.1. 细分市场中最有前途和高成长的机会是什么？
  • Q.2.哪个细分市场将以更快的速度成长？为什么？
  • Q.3.您认为哪些地区未来会出现更快的成长？为什么？
  • Q.4. 影响市场动态的主要因素有哪些？市场的主要挑战和商业风险是什么？
  • Q.5. 这个市场的商业风险和竞争威胁是什么？
  • Q.6.这个市场有哪些新趋势？为什么？
  • Q.7.市场客户需求有何改变？
  • Q.8. 该市场有哪些新发展以及哪些公司处于领先地位？
  • Q.9.这个市场的主要企业有哪些？主要企业采取哪些策略配合措施来发展业务？
  • Q.10. 该市场上的竞争产品有哪些？由于材料或产品替代而导致市场占有率下降的威胁有多大？
  • Q.11.过去年度发生了哪些併购事件，对产业产生了哪些影响？

目录

第1章执行摘要

第2章全球颅咽瘤治疗市场：市场动态

  • 简介、背景、分类
  • 供应链
  • 产业驱动因素与挑战

第3章2018-2030年市场趋势与预测分析

  • 宏观经济趋势（2018-2023）与预测（2024-2030）
  • 全球颅咽瘤治疗市场趋势（2018-2023）与预测（2024-2030）
  • 全球颅咽瘤治疗市场：依诊断分类
    • 磁振造影(MRI)
    • 电脑断层扫描 (CT)
    • 切片检查
    • 验血
    • 荷尔蒙测试
  • 全球颅咽瘤治疗市场：依治疗分类
    • 外科手术
    • 放射治疗
    • 化疗
    • 标靶治疗
    • 荷尔蒙替代疗法
  • 全球颅咽瘤治疗市场：依最终用途产业
    • 医院
    • 诊所
    • 门诊手术中心
    • 癌症研究
    • 诊断实验室
    • 其他的

第4章市场趋势与预测分析：按地区（2018-2030）

  • 全球颅咽瘤治疗市场：按地区
  • 北美颅咽瘤治疗市场
  • 欧洲颅咽瘤治疗市场
  • 亚太地区颅咽瘤治疗市场
  • 其他地区颅咽瘤治疗市场

第5章竞争分析

  • 产品系列分析
  • 营运整合
  • 波特五力分析

第6章成长机会与策略分析

  • 成长机会分析
    • 全球颅咽瘤治疗市场诊断成长机会
    • 全球颅咽瘤治疗市场的成长机会（依治疗）
    • 全球颅咽瘤治疗市场最终用途产业的成长机会
    • 全球颅咽瘤治疗市场按地区成长机会
  • 全球颅咽瘤治疗市场的新趋势
  • 战略分析
    • 新产品开发
    • 扩大全球颅咽瘤治疗市场的产能
    • 全球颅咽瘤治疗市场的合併、收购与合资企业
    • 认证和许可

第7章主要企业概况

  • Pfizer
  • Novartis
  • Merck
  • Kazia Therapeutics
  • AbbVie
  • Bristol-Myers Squibb
  • F. Hoffmann-La Roche
  • Ipsen Biopharmaceuticals
  • Johnson & Johnson
简介目录

Craniopharyngioma Treatment Trends and Forecast

The future of the global craniopharyngioma treatment market looks promising with opportunities in the hospital, clinic, ambulatory surgical center, cancer research institute, and diagnostic laboratory markets. The global craniopharyngioma treatment market is expected to reach an estimated $0.02 billion by 2030 with a CAGR of 7.1% from 2024 to 2030. The major drivers for this market are the increasing incidence of brain cancer across the globe, growing healthcare expenditure, and on-going advancement in imaging technology, radiation therapy, and surgical techniques.

A more than 150-page report is developed to help in your business decisions.

Craniopharyngioma Treatment by Segment

The study includes a forecast for the global craniopharyngioma treatment by diagnosis, treatment, end use industry, and region.

Craniopharyngioma Treatment Market by Diagnosis [Shipment Analysis by Value from 2018 to 2030]:

  • Magnetic Resonance Imaging (MRI)
  • Computed Tomography (CT)
  • Biopsy
  • Biopsy
  • Hormone Tests

Craniopharyngioma Treatment Market by Treatment [Shipment Analysis by Value from 2018 to 2030]:

  • Surgery
  • Radiation Therapy
  • Chemotherapy
  • Targeted Therapy
  • Hormone Replacement Therapy

Craniopharyngioma Treatment Market by End Use Industry [Shipment Analysis by Value from 2018 to 2030]:

  • Hospitals
  • Clinics
  • Ambulatory Surgical Centers
  • Cancer Research Institutes
  • Diagnostic Laboratories
  • Others

Craniopharyngioma Treatment Market by Region [Shipment Analysis by Value from 2018 to 2030]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

List of Craniopharyngioma Treatment Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies craniopharyngioma treatment companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the craniopharyngioma treatment companies profiled in this report include-

  • Pfizer
  • Novartis
  • Merck
  • Kazia Therapeutics
  • Abbvie
  • Bristol-Myers Squibb
  • F. Hoffmann-La Roche
  • Ipsen Biopharmaceuticals
  • Johnson & Johnson

Craniopharyngioma Treatment Market Insights

Lucintel forecasts that magnetic resonance imaging (MRI) will remain the largest segment over the forecast period due to its ability to develop detailed images of the brain and pituitary gland.

Within this market, hospital will remain the largest segment due to the facilities provided by hospitals, availability of highly skilled healthcare professionals, and presence of cutting-edge medical technology.

North America will remain the largest segment over the forecast period due to the increasing prevalence of craniopharyngioma, presence of advanced healthcare infrastructure, and favorable reimbursement policies in the region.

Features of the Global Craniopharyngioma Treatment Market

Market Size Estimates: Craniopharyngioma treatment market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Craniopharyngioma treatment market size by diagnosis, treatment, end use industry, and region in terms of value ($B).

Regional Analysis: Craniopharyngioma treatment market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different diagnosis, treatment, end use industries, and regions for the craniopharyngioma treatment market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the craniopharyngioma treatment market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q.1 What is the craniopharyngioma treatment market size?

Answer: The global craniopharyngioma treatment market is expected to reach an estimated $0.02 billion by 2030.

Q.2 What is the growth forecast for craniopharyngioma treatment market?

Answer: The global craniopharyngioma treatment market is expected to grow with a CAGR of 7.1% from 2024 to 2030.

Q.3 What are the major drivers influencing the growth of the craniopharyngioma treatment market?

Answer: The major drivers for this market are the increasing incidence of brain cancer across the globe, growing healthcare expenditure, and on-going advancement in imaging technology, radiation therapy, and surgical techniques.

Q4. What are the major segments for craniopharyngioma treatment market?

Answer: The future of the craniopharyngioma treatment market looks promising with opportunities in the hospital, clinic, ambulatory surgical center, cancer research institute, and diagnostic laboratory markets.

Q5. Who are the key craniopharyngioma treatment market companies?

Answer: Some of the key craniopharyngioma treatment companies are as follows:

  • Pfizer
  • Novartis
  • Merck
  • Kazia Therapeutics
  • AbbVie
  • Bristol-Myers Squibb
  • F. Hoffmann-La Roche
  • Ipsen Biopharmaceuticals
  • Johnson & Johnson

Q6. Which craniopharyngioma treatment market segment will be the largest in future?

Answer: Lucintel forecasts that magnetic resonance imaging (MRI) will remain the largest segment over the forecast period due to its ability to develop detailed images of the brain and pituitary gland.

Q7. In craniopharyngioma treatment market, which region is expected to be the largest in next 5 years?

Answer:North America will remain the largest segment over the forecast period due to the increasing prevalence of craniopharyngioma, presence of advanced healthcare infrastructure, and favorable reimbursement policies in the region.

Q.8 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

  • Q.1. What are some of the most promising, high-growth opportunities for the craniopharyngioma treatment market by diagnosis (magnetic resonance imaging (MRI), computed tomography (CT), biopsy,blood tests, and hormone tests), treatment (surgery, radiation therapy, chemotherapy, targeted therapy, and hormone replacement therapy), end use industry (hospitals, clinics, ambulatory surgical centers, cancer research institutes, diagnostic laboratories, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2. Which segments will grow at a faster pace and why?
  • Q.3. Which region will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q.5. What are the business risks and competitive threats in this market?
  • Q.6. What are the emerging trends in this market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the market?
  • Q.8. What are the new developments in the market? Which companies are leading these developments?
  • Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
  • Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Craniopharyngioma Treatment Market : Market Dynamics

  • 2.1: Introduction, Background, and Classifications
  • 2.2: Supply Chain
  • 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

  • 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
  • 3.2. Global Craniopharyngioma Treatment Market Trends (2018-2023) and Forecast (2024-2030)
  • 3.3: Global Craniopharyngioma Treatment Market by Diagnosis
    • 3.3.1: Magnetic Resonance Imaging (MRI)
    • 3.3.2: Computed Tomography (CT)
    • 3.3.3: Biopsy
    • 3.3.4: Blood Tests
    • 3.3.5: Hormone Tests
  • 3.4: Global Craniopharyngioma Treatment Market by Treatment
    • 3.4.1: Surgery
    • 3.4.2: Radiation Therapy
    • 3.4.3: Chemotherapy
    • 3.4.4: Targeted Therapy
    • 3.4.5: Hormone Replacement Therapy
  • 3.5: Global Craniopharyngioma Treatment Market by End Use Industry
    • 3.5.1: Hospitals
    • 3.5.2: Clinics
    • 3.5.3: Ambulatory Surgical Centers
    • 3.5.4: Cancer Research Institutes
    • 3.5.5: Diagnostic Laboratories
    • 3.5.6: Others

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

  • 4.1: Global Craniopharyngioma Treatment Market by Region
  • 4.2: North American Craniopharyngioma Treatment Market
    • 4.2.2: North American Craniopharyngioma Treatment Market by End Use Industry: Hospitals, Clinics, Ambulatory Surgical Centers, Cancer Research Institutes, Diagnostic Laboratories, and Others
  • 4.3: European Craniopharyngioma Treatment Market
    • 4.3.1: European Craniopharyngioma Treatment Market by Diagnosis: Magnetic Resonance Imaging (MRI), Computed Tomography (CT), Biopsy, Blood Tests, and Hormone Tests
    • 4.3.2: European Craniopharyngioma Treatment Market by End Use Industry: Hospitals, Clinics, Ambulatory Surgical Centers, Cancer Research Institutes, Diagnostic Laboratories, and Others
  • 4.4: APAC Craniopharyngioma Treatment Market
    • 4.4.1: APAC Craniopharyngioma Treatment Market by Diagnosis: Magnetic Resonance Imaging (MRI), Computed Tomography (CT), Biopsy, Blood Tests, and Hormone Tests
    • 4.4.2: APAC Craniopharyngioma Treatment Market by End Use Industry: Hospitals, Clinics, Ambulatory Surgical Centers, Cancer Research Institutes, Diagnostic Laboratories, and Others
  • 4.5: ROW Craniopharyngioma Treatment Market
    • 4.5.1: ROW Craniopharyngioma Treatment Market by Diagnosis: Magnetic Resonance Imaging (MRI), Computed Tomography (CT), Biopsy, Blood Tests, and Hormone Tests
    • 4.5.2: ROW Craniopharyngioma Treatment Market by End Use Industry: Hospitals, Clinics, Ambulatory Surgical Centers, Cancer Research Institutes, Diagnostic Laboratories, and Others

5. Competitor Analysis

  • 5.1: Product Portfolio Analysis
  • 5.2: Operational Integration
  • 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

  • 6.1: Growth Opportunity Analysis
    • 6.1.1: Growth Opportunities for the Global Craniopharyngioma Treatment Market by Diagnosis
    • 6.1.2: Growth Opportunities for the Global Craniopharyngioma Treatment Market by Treatment
    • 6.1.3: Growth Opportunities for the Global Craniopharyngioma Treatment Market by End Use Industry
    • 6.1.4: Growth Opportunities for the Global Craniopharyngioma Treatment Market by Region
  • 6.2: Emerging Trends in the Global Craniopharyngioma Treatment Market
  • 6.3: Strategic Analysis
    • 6.3.1: New Product Development
    • 6.3.2: Capacity Expansion of the Global Craniopharyngioma Treatment Market
    • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Craniopharyngioma Treatment Market
    • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

  • 7.1: Pfizer
  • 7.2: Novartis
  • 7.3: Merck
  • 7.4: Kazia Therapeutics
  • 7.5: AbbVie
  • 7.6: Bristol-Myers Squibb
  • 7.7: F. Hoffmann-La Roche
  • 7.8: Ipsen Biopharmaceuticals
  • 7.9: Johnson & Johnson